United States: HHS Finalizes Interpretations Of Genetic Information And Genetic Nondiscrimination In Omnibus Final Rule

The Omnibus Final Rule issued by the Department of Health and Human Services in January 2013 set forth implementing regulations not only pursuant to the Health Information Technology for Economic and Clinical Health Act (HITECH Act) but also pursuant to the Genetic Information Nondiscrimination Act of 2008 (GINA). The Omnibus Final Rule contains a number of modifications and clarifications that are significant to the use of genetic information and family medical history by covered entities, business associates and other healthcare entities. In the Omnibus Final Rule, HHS 1) revised the HIPAA Privacy Rule (Privacy Rule) to clarify that genetic information is health information, and 2) prohibited the use or disclosure of genetic information for underwriting purposes for all health plans subject to the Privacy Rule, except long-term-care insurers.

HHS's enhancement of the privacy accorded to genetic information is significant because genetic testing is used with increasing frequency to determine the likelihood or presence of disease manifestation or the suitability of a particular method of treatment, and it impacts not only the individual whose genetic information was used but also the family members who share the genetic code. Furthermore, HHS's expansive view of entities forbidden to use or disclose genetic information for underwriting purposes limits the ability of insurance providers to require genetic testing or discriminate in the amount of contributions or premiums paid by an individual based on their genetic information. (See 78 Fed. Reg. 5658-59).

Clarifying Definitions

In employment and health coverage contexts GINA prohibits discrimination based on an individual's genetic information. The Omnibus Final Rule modified or added the applicable definitions for "health information," "family member," "genetic information," "genetic services," "genetic test," "manifestation or manifested" and "health plan." (45 C.F.R. 160.103). Key definitions are:

1. Family Member

A family member is either a dependent or a first- through fourth-degree relative by either affinity (marriage or adoption) or consanguinity (biological). Half-siblings or less than full-consanguinity are treated as if they are full relatives.

2. Genetic Information

Genetic information includes (i) individual genetic tests; (ii) manifestation of a disease or disorder in family members of such an individual (e.g., family medical history); or (iii) any request for or receipt of genetic services, or participation in clinical research that includes genetic services, by the individual or any family member of the individual. This information includes the genetic information of a fetus or any embryo legally held by an individual or family member utilizing assisted reproductive technology, but does not include information about the sex or age of an individual. (45 C.F.R. 160.103).

For example, the diagnosis of a parent with Huntington's disease or the results of a test for the BRCAI gene associated with breast cancer constitute genetic information. Genetic information does not include age or gender.

3. Genetic Test

A genetic test is "an analysis of human DNA, RNA, chromosomes, proteins or metabolites if the analysis detects genotypes, mutations, or chromosomal changes. A genetic test does not include an analysis of proteins or metabolites that is directly related to a manifested disease, disorder, or pathological condition." (45 C.F.R. 160.103).

A BRAC1 test or a test for the genetic marker for a particular type of colon cancer are genetic tests. Genetic tests do not include HIV tests, complete blood counts, cholesterol tests, liver function tests or tests for the presence of alcohol or drugs. The genetic testing and personalized medicine industry is rapidly evolving with, for example, the use of over-the-counter genetic tests and genetic tests to determine whether a particular medication will be beneficial for a particular individual. Therefore, HHS intends to issue further guidance on what tests are considered genetic tests. (78 Fed. Reg. 5662).

4. Manifestation or Manifested

Manifestation or manifested means "with respect to a disease, disorder, or pathological condition that an individual has been or could reasonably be diagnosed with the disease, disorder, or pathological condition by a health care professional with appropriate training and expertise in the field of medicine involved.... [A] disease, disorder, or pathological condition is not manifested if the diagnosis is based principally on genetic information." (45 C.F.R. 160.103).

The definition of manifestation incorporates both family medical history and genetic testing into the definition of genetic information. For example, if an individual has several family members who were diagnosed with colon cancer, the individual undergoes a genetic test to identify whether the individual has the HNPCC mutation and the test results are positive, but the individual's colonoscopy is clear, then the individual has not manifested the disease of colon cancer. All information about the individual's potential future manifestation of colon cancer is based on genetic information. If, and when, the individual displays polyps or other symptoms particular to colon cancer, then the individual will have the manifestation of colon cancer. (See 78 Fed. Reg. 5663-64).

Alternatively, if an individual is displaying symptoms of Huntington's disease, the neurologist uses the Huntington's disease genetic test to determine whether the individual has the mutation and the results of the test are positive for the mutation, then the disease has manifested even though genetic information was used to diagnose the disease. Here, genetic information was not the sole or even principal basis for diagnosing the illness. As the field of genetic testing and genetic manifestation of disease expands, HHS plans to issue guidance on manifestation and the Privacy Rule's protection for genetic information. (See 78 Fed. Reg. 5663-64).

Prohibition of the Use of Genetic Information in Underwriting and the Exception for Long-Term Care

Title I of GINA calls for HHS to prohibit group health plans, health insurance issuers (including HMOs) and issuers of Medicare supplemental insurance plans (Medigap policies) from using or disclosing genetic information for underwriting purposes. A health plan must now state in its Notice of Privacy Practices that it is prohibited from using or disclosing for underwriting purposes PHI that is genetic information of an individual. HHS defines "underwriting purposes" to include (i) rules for or determination of eligibility for benefits under a health plan; (ii) the computation of premiums or contribution amounts under a plan (including discounts, rebates or other premium differential mechanisms in return for activities such as participating in a wellness program); (iii) the application of any pre-existing condition exclusion under the plan; and (iv) other activities related to the creation, renewal or replacement of a contract of health insurance or health benefits. (45 C.F.R. 164.502(5)(i)).

Underwriting purposes, however, do not include the "determination of medical appropriateness where an individual seeks a benefit under the plan, coverage, or policy." (45 C.F.R. 164.502(a)(5)(i)). For example, a health insurance plan can use the results of a genetic test to decide whether a particular chemotherapy drug is medically appropriate for the individual even though the drug may be covered under the health plan.

In the Omnibus Final Rule, HHS expanded the types of insurance issuers who are prohibited from using genetic information when underwriting policies. Originally, HHS proposed to prohibit all health plans subject to the Privacy Rule from using genetic information when underwriting policies. In the Omnibus Final Rule, however, HHS exempted long-term-care insurance from the prohibition on the use of genetic information when underwriting policies. (45 C.F.R. 164.502(a)(5)(i) and 78 Fed. Reg. 5665). HHS "acknowledge[d] that, at [that] time, it [did] not have the information necessary to more precisely and carefully measure the ... impact on the long-term market in order to appropriately balance an individual's privacy interests with such an impact." (78 Fed. Reg. 5661). HHS stated that it is seeking further information on the issue and further rulemaking may prohibit the use of genetic information in underwriting for long-term-care insurance.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions